Cosgrove, S. B., Wren, J. A., Cleaver, D. M., Walsh, K. F., Follis, S. I., King, V. I., . . . Stegemann, M. R. (2013). A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel(®)) in client‐owned dogs with atopic dermatitis. Vet Dermatol.
Styl ChicagoCosgrove, Sallie B., Jody A. Wren, Dawn M. Cleaver, Kelly F. Walsh, Stacey I. Follis, Vickie I. King, Jezaniah‐Kira S. Tena, a Michael R. Stegemann. "A Blinded, Randomized, Placebo‐controlled Trial of the Efficacy and Safety of the Janus Kinase Inhibitor Oclacitinib (Apoquel(®)) in Client‐owned Dogs With Atopic Dermatitis." Vet Dermatol 2013.
Citace podle MLACosgrove, Sallie B., et al. "A Blinded, Randomized, Placebo‐controlled Trial of the Efficacy and Safety of the Janus Kinase Inhibitor Oclacitinib (Apoquel(®)) in Client‐owned Dogs With Atopic Dermatitis." Vet Dermatol 2013.